combined therapy with erythromycin and rifampicin may be justified in patients with confirmed legionnaires ' disease who are not responding to erythromycin alone or as part of a controlled antibiotic trial among suspected cases during an outbreak of legionnaires ' disease .
C0035608
rifampicin
C0023241
legionnaires